biotech / news / / Pittsburgh Tribune-Review
Novo Nordisk says it will seek federal approval to expand the use of its Ozempic and Rybelsus pills.
Novo Nordisk will seek FDA approval to expand Ozempic and Rybelsus use for minors.
KEY POINTS
- No oral GLP-1 drugs are FDA approved for kids and teenagers with Type 2 diabetes.
- A stage 3 trial showed Ozempic and Rybelsus pills are effective and have limited side effects.
- Rybelsus exists only as a pill, while Ozempic is available in both injection and soon pill form.
COMPANIES
Summarized by Newsio from Pittsburgh Tribune-Review. How we summarize →